Susceptibility to spondyloarthropaties is strongly associated with some HLA‐B27 alleles. Evidence suggests a direct pathogenic role for the B27 molecules which possibly present an arthritogenic peptide to the T cells. If this hypothesis is true, B27 subtypes that differ structurally but are disease‐associated ought to be capable of presenting such peptide(s), while non‐disease‐associated ones would not. We have recently described a B27 subtype, B*2709, and shown its absence in ankylosing spondylitis (AS) patients. Here, we show the elution and sequence of peptides from HLA‐B*2709 molecules. Similar to other B27 subtypes, these peptides are mainly nonamers with an Arg at position P2. Comparison of the C‐terminal anchors of peptides eluted from B*2702 and B*2705 with those eluted from B*2709 reveals that, while B*2702 and B*2705 have a broader specificity, B*2709 molecules appear to only accept C‐terminal hydrophobic residues. A common feature shared by the two caucasoid AS‐associated subtypes (B*2702 and B*2705) but different from B*2709, is the presence of a Tyr as peptide C‐terminal anchor. The substitution of Val for Tyr at the C terminus in one of the eluted peptides greatly reduces the binding to B*2709 molecules. This finding suggests Tyr as a discriminative amino acid allowed at the C terminus of peptides bound to the AS‐associated B27 subtypes, but not to those which are not associated with AS.